Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.
SB2185 • 2026
CD CORR-OPIOID USE DISORDER
This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.
Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.
CD CORR-OPIOID USE DISORDER
These notes stay tied to the official amendment files and metadata from the legislature.
Plain English: Illinois General Assembly - Full Text of SB2185 Select Language × The Illinois General Assembly offers the Google Translate™ service for visitor convenience.
Plain English: Illinois General Assembly - Full Text of SB2185 Select Language × The Illinois General Assembly offers the Google Translate™ service for visitor convenience.
Rule 3-9(a) / Re-referred to Assignments
Rule 2-10 Committee/3rd Reading Deadline Established As May 22, 2026
Rule 2-10 Committee/3rd Reading Deadline Established As May 15, 2026
Added as Co-Sponsor Sen. Mary Edly-Allen
Added as Co-Sponsor Sen. Elgie R. Sims, Jr.
Rule 2-10 Committee Deadline Established As April 24, 2026
Added as Co-Sponsor Sen. Suzy Glowiak Hilton
Senate Committee Amendment No. 3 Adopted
Do Pass as Amended Criminal Law ; 006-003-000
Re-assigned to Appropriations- Public Safety and Infrastructure
Senate Committee Amendment No. 3 Assignments Refers to Criminal Law
Senate Committee Amendment No. 3 Filed with Secretary by Sen. Rachel Ventura
Senate Committee Amendment No. 3 Referred to Assignments
Directed to Multiple Committees Re-assigned to Criminal Law then to Appropriations- Public Safety & Infrastructure
Re-assigned to Criminal Law
Senate Committee Amendment No. 2 Directed to Multiple Committees Re-assigned to Criminal Law then to Appropriations- Public Safety & Infrastructure
Senate Committee Amendment No. 2 Re-assigned to Criminal Law
Rule 3-9(a) / Re-referred to Assignments
Senate Committee Amendment No. 2 Rule 3-9(a) / Re-referred to Assignments
Rule 2-10 Committee/3rd Reading Deadline Established As June 1, 2025
Rule 2-10 Committee/3rd Reading Deadline Established As May 23, 2025
Rule 2-10 Committee Deadline Established As May 9, 2025
Senate Committee Amendment No. 2 Assignments Refers to Appropriations- Public Safety and Infrastructure
Senate Committee Amendment No. 2 Filed with Secretary by Sen. Rachel Ventura
Senate Committee Amendment No. 2 Referred to Assignments
Rule 2-10 Committee Deadline Established As April 11, 2025
Added as Chief Co-Sponsor Sen. Napoleon Harris, III
Added as Co-Sponsor Sen. Adriane Johnson
Do Pass as Amended Criminal Law ; 006-002-000
Assigned to Appropriations- Public Safety and Infrastructure
Senate Committee Amendment No. 1 Adopted
Senate Committee Amendment No. 1 Assignments Refers to Criminal Law
Senate Committee Amendment No. 1 Filed with Secretary by Sen. Rachel Ventura
Senate Committee Amendment No. 1 Referred to Assignments
Directed to Multiple Committees Refer to Criminal Law Committee then Appropriation-Public Safety & Infrastructure
Assigned to Criminal Law
Filed with Secretary by Sen. Rachel Ventura
First Reading
Referred to Assignments
CD CORR-OPIOID USE DISORDER
Illinois General Assembly - Full Text of SB2185 Select Language × The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein. Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet. The English language version is always the official and authoritative version of this website. NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window. Choose Language English Afrikaans Albanian Arabic Armenian Azerbaijani Basque Bengali Bosnian Catalan Croatian Czech Danish Dutch Esperanto Estonian Filipino Finnish French Galician Georgian German Greek Gujarati Haitian Creole Hausa Hawaiian Hebrew Hindi Hungarian Icelandic Indonesian Interlingua Interlingue Inuktitut Irish Italian Japanese Javanese Kannada Khmer Korean Latin Latvian Lithuanian Luxembourgish Macedonian Malagasy Malayalam Maltese Maori Marathi Myanmar Nepali Norwegian Odia Pashto Punjabi Romanian Russian Samoan Sango Sanskrit Sardinian Sindhi Sinhala Slovak Slovenian Somali Southern Sotho Spanish Sundanese Swahili Swedish Tamil Telugu Thai Tigrinya Tonga Turkish Ukrainian Urdu Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Powered by Translate Close Illinois General Assembly Top Navigation Bar Translate Learn Select General Assembly Search the 104th General Assembly Enter search terms for legislation, members, committees, or schedules. ILGA.GOV LEGISLATION & LAWS Bills & Resolutions Public Acts Illinois Compiled Statutes Illinois Constitution Search Legislation Glossary Guide Reports & Inquiry Legislative Reports Special Reports FTP Site Legislator Lookup Capitol Complex Phone Numbers Rules & Regulations Illinois Register Administrative Rules Senate Members Schedules Committees Request for Remote Testimony Journals Transcripts Rules Audio/Video FOIA Information Senate Employment Opportunities Media Guidelines House Members Schedules Committees Submit testimony for House Committees Journals Transcripts Rules Audio/Video FOIA Information House Employment Opportunities Log In Mobile Top Bar Search the 104th General Assembly Enter keywords to search the Illinois General Assembly website. Full Text of SB2185 Home Legislation Full Text SB2185 - 104th General Assembly Bill Status Full Text Votes Witness Slips Select Menu Bill Status Full Text Votes Witness Slips Printer Friendly Version Introduced Senate Amendment 001 Senate Amendment 002 Senate Amendment 003 Printer Friendly Version Introduced Senate Amendment 001 Senate Amendment 002 Senate Amendment 003 Open PDF 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB2185 Introduced 2/7/2025, by Sen. Rachel Ventura SYNOPSIS AS INTRODUCED: 730 ILCS 5/3-6-2.1 new Amends the Unified Code of Corrections. Provides within 24 hours of admission to a correctional institution or facility of the Department of Corrections, each committed person shall be screened for substance use disorders as part of an initial and ongoing substance use screening and assessment process. Provides that this process includes screening and assessment for opioid use disorders. Provides that if at any time a committed person screens positive as having or being at risk for an opioid use disorder, is diagnosed with an opioid use disorder or is exhibiting symptoms of withdrawal from an opioid use disorder, and medication assisted treatment is clinically indicated by a licensed physician, a licensed physician assistant, or a licensed nurse practitioner, then the individual may consent to commence medications for opioid use disorder, which shall be provided by the Department. Provides that the committed person shall be authorized to receive the medication immediately and for as long as clinically indicated. Provides that upon reentry, the Department shall provide an individual participating in medication assisted treatment with a referral to a community-based provider who may assist the individual with continued medications for opioid use disorder and medication assisted treatment care. LRB104 10818 RLC 20899 b A BILL FOR SB2185 LRB104 10818 RLC 20899 b 1 AN ACT concerning criminal law. 2 Be it enacted by the People of the State of Illinois, 3 represented in the General Assembly: 4 Section 5. The Unified Code of Corrections is amended by 5 adding Section 3-6-2.1 as follows: 6 (730 ILCS 5/3-6-2.1 new) 7 Sec. 3-6-2.1. Medication for opioid use disorder. 8 (a) In this Section: 9 "Clinically indicated" means a medical procedure or 10 treatment is based upon the treatment provider's medical 11 judgment in accordance with the current generally accepted 12 standards of care. 13 "Medication assisted treatment" means the use of U.S. 14 Federal Drug Administration-approved medications, in 15 combination with counseling and behavioral therapies, to 16 provide a whole patient approach to the treatment of substance 17 use disorders. 18 "Medications for opioid use disorder" means the use of 19 U.S. Federal Drug Administration-approved medications to treat 20 substance use disorders. 21 (b) Within 24 hours of admission to a correctional 22 institution or facility, each committed person shall be 23 screened for substance use disorders as part of an initial and SB2185 - 2 - LRB104 10818 RLC 20899 b 1 ongoing substance use screening and assessment process. This 2 process includes screening and assessment for opioid use 3 disorders. 4 (c) A committed person who is admitted to a correctional 5 institution or facility while under the medical care of a 6 licensed physician, a licensed physician assistant, or a 7 licensed nurse practitioner and who is taking medication at 8 the time of admission pursuant to a valid prescription as 9 verified by the individual's pharmacy of record, primary care 10 provider, other licensed care provider, or a prescription 11 monitoring or information system, shall have that medication 12 continued and provided by the Department pending an evaluation 13 by a licensed physician, a licensed physician assistant, or a 14 licensed nurse practitioner and subject to the treatment 15 provider's medical judgment. The Department may defer 16 provision of a validly prescribed medication in accordance 17 with this subsection if, in the judgment of a licensed 18 physician, a licensed physician assistant, or a licensed nurse 19 practitioner, continuation of the medication is no longer 20 clinically indicated. 21 A committed person who is admitted to a correctional 22 institution or facility while under the medical care of a 23 licensed physician, a licensed physician assistant, or a 24 licensed nurse practitioner and who is taking medication for 25 an opioid use disorder or participating in medication assisted 26 treatment at the time of admission pursuant to a valid SB2185 - 3 - LRB104 10818 RLC 20899 b 1 prescription as verified by the individual's pharmacy of 2 record, primary care provider, other licensed care provider, 3 or a prescription monitoring or information system, shall have 4 the committed person's medication continued and provided by 5 the Department pending an evaluation by a licensed physician, 6 a licensed physician assistant, or a licensed nurse 7 practitioner and subject to the treatment provider's medical 8 judgment. The Department may defer provision of a validly 9 prescribed medication in accordance with this subsection if, 10 in the judgment of a licensed physician, a licensed physician 11 assistant, or a licensed nurse practitioner, continuation of 12 the medication is no longer clinically indicated. An 13 individual participating in a medication assisted treatment 14 program may have counseling and behavioral therapies continued 15 to the extent possible. 16 If at any time a committed person screens positive as 17 having or being at risk for an opioid use disorder, is 18 diagnosed with an opioid use disorder or is exhibiting 19 symptoms of withdrawal from an opioid use disorder, and 20 medication assisted treatment is clinically indicated by a 21 licensed physician, a licensed physician assistant, or a 22 licensed nurse practitioner, then the individual may consent 23 to commence medications for opioid use disorder, which shall 24 be provided by the Department. The committed person shall be 25 authorized to receive the medication immediately and for as 26 long as clinically indicated. SB2185 - 4 - LRB104 10818 RLC 20899 b 1 (d) The licensed practitioner who makes the clinical 2 judgment to discontinue the use of medication shall enter the 3 reason for the discontinuance to be entered into the committed 4 person's medical record, specifically stating the reason for 5 discontinuance. The individual shall be provided, both orally 6 and in writing, with a specific explanation of the decision to 7 discontinue the medication. 8 (e) As part of the reentry planning, the Department shall 9 commence medications for opioid use disorder prior to an 10 individual's release if: 11 (1) the individual screens positive as having an 12 opioid use disorder, being at risk for an opioid use 13 disorder, or exhibiting symptoms of withdrawal from an 14 opioid use disorder; 15 (2) medication assisted treatment is clinically 16 indicated by a licensed physician, a licensed physician 17 assistant, or a licensed nurse practitioner; and 18 (3) The individual consents to commence medications 19 for opioid use disorder. 20 Upon reentry, the Department shall provide an individual 21 participating in medication assisted treatment with a referral 22 to a community-based provider who may assist the individual 23 with continued medications for opioid use disorder and 24 medication assisted treatment care. Footer Disclaimer This site is maintained for the Illinois General Assembly by the Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706. Contact ILGA Webmaster ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies. Read About Cookies ILGA.GOV 2026 ILGA.gov | All Rights Reserved | ADA | Disclaimers | Learn This site is maintained for the Illinois General Assembly by the Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706. Contact ILGA Webmaster ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies. Read About Cookies ILGA.GOV 2026 ILGA.gov | All Rights Reserved | ADA | Disclaimers | Learn